Angel F. López

South Australia Pathology — Australia

Immunology and Microbiology · Life Sciences

73h-index18.0kcitations476works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(106), Immune Response and Inflammation(83), Cytokine Signaling Pathways and Interactions(79), Monoclonal and Polyclonal Antibodies Research(57), Chronic Myeloid Leukemia Treatments(50)

Publications476 total

Coccidioidomicosis diseminada en paciente con artritis reumatoide
LATAM Revista Latinoamericana de Ciencias Sociales y Humanidades·2026Open Access
El giro antivacunas de EE. UU. llega a los móviles
2026
Ultraprecision Therapy for Type 1 vs Type 2 CALR+ MPN by Dual Epitope Targeting that Restores Ruxolitinib Sensitivity
Blood·2026
Between Borders and Generations
2026
βc receptor antagonism mitigates sarcoidosis granuloma formation by targeting inflammatory signals and aberrant lipid metabolism
Frontiers in Immunology·2025Open Access
Supplementary Table S2 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
2025Open Access
Figure S5 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
2025Open Access
Figure S4 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
2025Open Access
Figure S7 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
2025Open Access
Figure S1 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
2025Open Access
Figure S3 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
2025Open Access
Figure S6 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
2025Open Access
Figure S2 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
2025Open Access
Supplementary Table S1 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
2025Open Access
Supplementary Methods from Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches
2025Open Access
Supplementary Figure S1 from Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches
2025Open Access
Supplementary File 2 from Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches
2025Open Access
Supplementary Movie from Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches
2025Open Access
Family Attitude of Critically Ill Patients Regarding the Risk of Death in an Intensive Care Unit of a Highly Specialized Medical Center
International journal of research and scientific innovation·2025Open Access
TGF-β regulates CD123 and chemotherapy resistance in Acute Myeloid Leukemia stem cells
Blood·2025
page 1 of 24Next →

Frequent Co-authors

Hayley S. Ramshaw(10), Joanna M. Woodcock(10), M A Vadas(7), C. Glenn Begley(7), Timothy R. Hercus(7), Jennifer R. Gamble(5), Mark A. Guthridge(5), Nicos A. Nicola(5), MA Vadas(5), Frank C. Stomski(5), Michael W. Parker(5), Mathew A. Vadas(5), Samantha J. Busfield(4), Danièl Thomas(4), D Metcalf(4), Mara Dottore(4), Colin J. Sanderson(3), G Vairo(3), SC Clark(3), J. A. J. Barbara(3)